The phosphorylation status of RB was therefore assessed following a 24‐h exposure to CCT068127 or seliciclib in HT29, RKO, and COLO205 human colon cancer cells (Figs 2A and S2A). This evidence concerns the gene RB1 and colonic neoplasm.